Associated Papers
Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia.
Dagli-Hernandez C et al.
Pharmaceutics, 2022
35631530 (PubMed )
Supplement: pharmaceutics-14-00944-s001.zip › pharmaceutics-1634615-supplementary.pdf
The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.
Koonrungsesomboon N et al.
The Pharmacogenomics Journal, 2018
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
Nebert DW et al.
Drug Metabolism Reviews, 2008
A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
Pitarque M et al.
Human Mutation, 2004
Select a paper to view details